Ligand Pharmaceuticals
LGND
#4138
Rank
โ‚น186.07 B
Marketcap
โ‚น9,848
Share price
4.47%
Change (1 day)
102.04%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): โ‚น128.21

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น132.65. In 2022 the company made an earnings per share (EPS) of -โ‚น167.30 a decrease over its 2021 EPS that were of โ‚น292.34.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น128.21-176.63%
2022-โ‚น167.30-157.23%
2021โ‚น292.34-2571.43%
2020-โ‚น11.83-100.46%
2019โ‚น2,586353.48%
2018โ‚น570.321025%
2017โ‚น50.70-700%
2016-โ‚น8.45-100.87%
2015โ‚น976.731859.32%
2014โ‚น49.855.36%
2013โ‚น47.328.0704505322479E+18%
2012โ‚น0.0000000000-100%
2011โ‚น41.40-194.23%
2010-โ‚น43.94548.38%
2009-โ‚น6.78-98.7%
2008-โ‚น522.16-136.52%
2007โ‚น1,430-787.8%
2006-โ‚น207.85-14.58%
2005-โ‚น243.34-21.31%
2004-โ‚น309.24-55.15%
2003-โ‚น689.4681.33%
2002-โ‚น380.222.74%
2001-โ‚น370.08-45.93%
2000-โ‚น684.39-14.56%
1999-โ‚น800.99-45.52%
1998-โ‚น1,470-3.97%
1997-โ‚น1,531132.31%
1996-โ‚น659.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,196 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น30.42-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น295.78 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น153.92 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น157.16 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น458.73 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น335.44 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น432.60 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,190 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA